MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis

Yasushi Horimasu1, Shinichiro Ohshimo, Francesco Bonella

  • 1Department of Molecular and Internal Medicine, Graduate School of Biomedical Science, Hiroshima University, Hiroshima, Japan.

Respirology (Carlton, Vic.)
|January 13, 2015
PubMed
Abstract

Insights

The study confirms a link between the Mucin 5B (MUC5B) gene variant rs35705950 and idiopathic pulmonary fibrosis (IPF) in Japanese individuals. This genetic association, while present, is less pronounced than in German populations.

Area of Science:

  • Genetics
  • Pulmonology
  • Population Health

Background:

  • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a complex genetic component.
  • A specific single nucleotide polymorphism (SNP), rs35705950, in the Mucin 5B (MUC5B) gene promoter has been associated with IPF, primarily in Caucasian populations.

Purpose of the Study:

  • To investigate and confirm the association between the MUC5B gene variant rs35705950 and IPF in a Japanese population.
  • To compare the strength of this genetic association in Japanese and German cohorts.

Main Methods:

  • Genomic DNA was collected from 384 Japanese and 137 German subjects.
  • The rs35705950 SNP was genotyped using a commercially available assay.

Main Results:

  • Genotype distributions for rs35705950 differed significantly between Japanese and German cohorts across IPF patients, nonspecific interstitial pneumonia (NSIP) patients, and healthy subjects (HS).
  • The T allele frequency of rs35705950 was significantly higher in Japanese IPF patients (3.4%) compared to Japanese HS (0.8%) (P = 0.031).
  • The T allele frequency was substantially higher in German IPF patients (33.1%) compared to German HS (4.3%) (P < 0.001).

Conclusions:

  • The association between the MUC5B rs35705950 variant and IPF is confirmed in the Japanese population.
  • The genetic association of rs35705950 with IPF is weaker in the Japanese cohort compared to the German cohort.
  • This study provides the first validation of the rs35705950-IPF association in an East Asian ethnicity.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
72
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
901
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K